Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38% Market Closed
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nexgel Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Operating Income
-$3.5m
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Operating Income
$215m
CAGR 3-Years
53%
CAGR 5-Years
7%
CAGR 10-Years
9%
ICU Medical Inc
NASDAQ:ICUI
Operating Income
$53.9m
CAGR 3-Years
-27%
CAGR 5-Years
-24%
CAGR 10-Years
2%
Align Technology Inc
NASDAQ:ALGN
Operating Income
$679.5m
CAGR 3-Years
-11%
CAGR 5-Years
7%
CAGR 10-Years
13%
Lantheus Holdings Inc
NASDAQ:LNTH
Operating Income
$474.3m
CAGR 3-Years
N/A
CAGR 5-Years
53%
CAGR 10-Years
34%
Merit Medical Systems Inc
NASDAQ:MMSI
Operating Income
$152.7m
CAGR 3-Years
31%
CAGR 5-Years
34%
CAGR 10-Years
15%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Operating Income?
Operating Income
-3.5m USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Operating Income amounts to -3.5m USD.

What is Nexgel Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-13%

Over the last year, the Operating Income growth was -4%. The average annual Operating Income growth rates for Nexgel Inc have been -15% over the past three years , -13% over the past five years .

Back to Top